07:00 , Aug 15, 2013 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms Direct reprogramming of fibroblasts into induced hepatic stem cells (iHSCs) for liver regeneration iHSCs derived directly from fibroblasts could help treat liver diseases. In culture,...
07:00 , Apr 11, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Ovarian cancer HNF1 homeobox B (HNF1B) Patient studies suggest genetic and epigenetic variation in HNF1B could be useful for the classification...
08:00 , Feb 28, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes; obesity HNF1 homeobox B (HNF1B); microRNA-802 (miR-802) Mouse and human studies suggest inhibiting miR-802 or increasing HNF1B signaling could help treat obesity and...